WO2002038577A3 - Derives d'erythromycine a liberation prolongee - Google Patents
Derives d'erythromycine a liberation prolongee Download PDFInfo
- Publication number
- WO2002038577A3 WO2002038577A3 PCT/US2001/032055 US0132055W WO0238577A3 WO 2002038577 A3 WO2002038577 A3 WO 2002038577A3 US 0132055 W US0132055 W US 0132055W WO 0238577 A3 WO0238577 A3 WO 0238577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extended release
- long chain
- erythromycin derivatives
- erythromycin derivative
- release erythromycin
- Prior art date
Links
- 238000013265 extended release Methods 0.000 title abstract 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 3
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002861 polymer material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002541109A JP2004528272A (ja) | 2000-10-13 | 2001-10-12 | 持続型放出エリスロマイシン誘導体 |
AU2002239232A AU2002239232A1 (en) | 2000-10-13 | 2001-10-12 | Extended release erythromycin derivatives |
EP01986972A EP1333807A4 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
CA002425688A CA2425688A1 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68998800A | 2000-10-13 | 2000-10-13 | |
US06/689,988 | 2000-10-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002038577A2 WO2002038577A2 (fr) | 2002-05-16 |
WO2002038577A3 true WO2002038577A3 (fr) | 2002-09-19 |
Family
ID=24770642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/032055 WO2002038577A2 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1333807A4 (fr) |
JP (1) | JP2004528272A (fr) |
AU (1) | AU2002239232A1 (fr) |
CA (1) | CA2425688A1 (fr) |
MX (1) | MXPA03003146A (fr) |
WO (1) | WO2002038577A2 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122204B2 (en) | 2000-02-24 | 2006-10-17 | Advancis Pharmaceutical Corporation | Antibiotic composition with inhibitor |
US7282221B2 (en) | 2000-10-13 | 2007-10-16 | Middlebrook Pharmaceuticals, Inc. | Antiviral product, use and formulation thereof |
US8889187B2 (en) | 2000-02-24 | 2014-11-18 | Shionogi Inc. | Once a day amoxicillin product comprising immediate and delayed release dosage forms |
US9144548B2 (en) | 2003-08-12 | 2015-09-29 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
RU2440112C2 (ru) | 2004-11-04 | 2012-01-20 | Ксенопорт, Инк. | Пероральная дозированная форма габапентина замедленного высвобождения |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49107855A (fr) * | 1973-02-03 | 1974-10-14 | ||
JP2528652B2 (ja) * | 1987-03-30 | 1996-08-28 | エスエス製薬株式会社 | 持効性セフラジン製剤 |
US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
CA2085342A1 (fr) * | 1990-06-14 | 1991-12-15 | Milton R. Kaplan | Suspension aqueuse stable de medicament |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
JPH07267850A (ja) * | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
KR100404293B1 (ko) * | 1995-05-02 | 2004-02-18 | 다이쇼 세이야꾸 가부시끼가이샤 | 경구투여용조성물 |
US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
US5780604A (en) * | 1997-09-26 | 1998-07-14 | Abbott Laboratories | 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides |
JP2000169364A (ja) * | 1998-09-30 | 2000-06-20 | Taisho Pharmaceut Co Ltd | 経口製剤用粒子 |
EP1161956A4 (fr) * | 1999-03-17 | 2005-03-16 | Daiichi Seiyaku Co | Compositions medicamenteuses |
SI20244A (sl) * | 1999-05-19 | 2000-12-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Granulacija v talini |
-
2001
- 2001-10-12 WO PCT/US2001/032055 patent/WO2002038577A2/fr not_active Application Discontinuation
- 2001-10-12 MX MXPA03003146A patent/MXPA03003146A/es unknown
- 2001-10-12 AU AU2002239232A patent/AU2002239232A1/en not_active Abandoned
- 2001-10-12 EP EP01986972A patent/EP1333807A4/fr not_active Withdrawn
- 2001-10-12 JP JP2002541109A patent/JP2004528272A/ja active Pending
- 2001-10-12 CA CA002425688A patent/CA2425688A1/fr not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
Non-Patent Citations (1)
Title |
---|
See also references of EP1333807A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122204B2 (en) | 2000-02-24 | 2006-10-17 | Advancis Pharmaceutical Corporation | Antibiotic composition with inhibitor |
US8889187B2 (en) | 2000-02-24 | 2014-11-18 | Shionogi Inc. | Once a day amoxicillin product comprising immediate and delayed release dosage forms |
US7282221B2 (en) | 2000-10-13 | 2007-10-16 | Middlebrook Pharmaceuticals, Inc. | Antiviral product, use and formulation thereof |
US9144548B2 (en) | 2003-08-12 | 2015-09-29 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2002239232A1 (en) | 2002-05-21 |
CA2425688A1 (fr) | 2002-05-16 |
JP2004528272A (ja) | 2004-09-16 |
MXPA03003146A (es) | 2004-12-06 |
EP1333807A2 (fr) | 2003-08-13 |
WO2002038577A2 (fr) | 2002-05-16 |
EP1333807A4 (fr) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60006070D1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
AU2001271027A1 (en) | Ester derivatives | |
AU2002230689A1 (en) | Methods for detection of a nucleic acid by sequential amplification | |
AU2001284324A1 (en) | Controlled release formulation of erythromycin or a derivative thereof | |
AU3906701A (en) | Permeable composition, controlled release product and methods for the productionthereof | |
AU2001290075A1 (en) | Novel alkanoic acid derivatives | |
CA2313878A1 (fr) | Composition permettant d'eliminer les problemes de comportement chez les animaux de compagnie | |
AUPR183100A0 (en) | Wood products and processes for the preparation thereof | |
AU2001231730A1 (en) | Piperidyl carboxylic acids as integrin antagonists | |
WO2002038577A3 (fr) | Derives d'erythromycine a liberation prolongee | |
AU2001271085A1 (en) | Organic acid producing microorganism and process for preparing organic acids employing the same | |
ID29110A (id) | Komposisi dan proses untuk pemindahan gas-gas asam | |
AU2001232238A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
MXPA03002901A (es) | Derivados de acido propionico. | |
ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
AU2002214978A1 (en) | Beta-Thio-amino acids | |
HUP0302912A3 (en) | Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them | |
AU2001296089A1 (en) | Propionic acid based preservative agent for animal and vegetable products | |
AU2001271015A1 (en) | Article formed into honeycomb | |
DE602004005734D1 (de) | Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung | |
ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
AU2001255528A1 (en) | A member and a method for using the member to selectively create an item | |
AU2001227139A1 (en) | Injection molding composition comprising paper and method for preparing the same | |
ATE275140T1 (de) | Zns wirksame cyclobuta-indole-carboxamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische präparate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2425688 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002541109 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002239232 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001986972 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001986972 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001986972 Country of ref document: EP |